 |
TIMI Risk
Score for ST-Elevation Myocardial
Infarction (STEMI)
The TIMI risk score, based upon
data from 15,000 patients with
an ST segment elevation
myocardial infarction eligible
for fibrinolytic therapy, is a
simple arithmetic sum of eight
independent predictors of
mortality.
|
TIMI
Risk Score for STEMI |
|
Historical |
|
Age
65-74
>/=
75 |
2 points
3 points |
|
DM/HTN
or Angina |
1 point |
|
Exam |
|
SBP
<
100 |
3 points |
|
HR >
100 |
2 points |
|
Killip
II-IV |
2 points |
|
Weight
<
67 kg |
1 point |
|
Presentation |
|
Anterior STE or LBBB |
1 point |
|
Time
to rx > 4 hrs |
1 point |
|
Risk
Score = Total |
(0-14) |
DM, diabetes
mellitus; HTN, hypertension; SBP,
systolic blood pressure; HR,
heart rate; STE, ST elevation;
LBBB, left bundle branch block;
and rx, treatment.
|
Risk
Score |
Odds
of death by 30D* |
|
0 |
0.1
(0.1-0.2) |
|
1 |
0.3
(0.2-0.3) |
|
2 |
0.4
(0.3-0.5) |
|
3 |
0.7
(0.6-0.9) |
|
4 |
1.2
(1.0-1.5) |
|
5 |
2.2
(1.9-2.6) |
|
6 |
3.0
(2.5-3.6) |
|
7 |
4.8
(3.8-6.1) |
|
8 |
5.8
(4.2-7.8) |
|
>8 |
8.8
(6.3-12) |
|
*
referenced to average
mortality (95% confidence
intervals) |
References:
-
Morrow DA,
Antman EM, Charlesworth A,
Cairns R, Murphy SA, de Lemos
JA, Giugliano RP, McCabe CH,
Braunwald E. TIMI risk score
for ST-elevation myocardial
infarction: A convenient,
bedside, clinical score for
risk assessment at
presentation: An intravenous
nPA for treatment of
infarcting myocardium early II
trial substudy. Circulation.
2000 Oct 24;102(17):2031-7.
[Medline]
-
Morrow DA, Antman EM,
Parsons L, de Lemos JA,
Cannon CP, Giugliano
RP, McCabe CH, Barron
HV, Braunwald E.
Application of the
TIMI risk score for
ST-elevation MI in the
National Registry of
Myocardial Infarction
3. JAMA. 2001 Sep
19;286(11):1356-9.
[Medline]
Created: Feb 18, 2007
Last Modified:
02/18/2007
|
|